151pd * arid1a role in cell cycle regulation and proliferation in mouse and human gynaecological tissues reveals potential therapeutic targets
Conclusions: A core ARID1A-driven transcriptional programme, conserved accross normal tissues and species appears to exist, centred around regulation of genes involved in the G2/M checkpoint. ARID1A loss promotes proliferation in normal tissues, providing important clues as to the mechanisms of ARID1A-driven carcinogenesis. Mitotic kinases emerge as potential therapeutic targets in ARID1A mutant tumours, an observation that is not evident from studies in cancer cell lines.Disclosure: All authors have declared no conflicts of interest.
Source: Annals of Oncology - Category: Cancer & Oncology Authors: Gounaris, I., Brenton, J. Tags: basic science Source Type: research
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Clear Cell Carcinoma | Endometrial Cancer | Endometriosis | Genetics | OBGYN | Ovarian Cancer | Ovaries | Science | Study | Tamoxifen